SpringWorks Therapeutics, Inc.
NASDAQ:SWTX
33.52 (USD) • At close November 11, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 176.053 | 67.49 | 103.961 | 147.089 | 327.652 | 45.648 | 10.271 |
| Short Term Investments
| 303.149 | 524.722 | 269.54 | 361.395 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 479.202 | 597.006 | 373.501 | 508.484 | 327.652 | 45.648 | 10.271 |
| Net Receivables
| 5.93 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 3.103 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 12.677 | 7.548 | 9.409 | 4.914 | 3.709 | 1.382 | 0.27 |
| Total Current Assets
| 500.912 | 599.76 | 382.91 | 513.398 | 331.361 | 47.03 | 10.541 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 24.087 | 18.269 | 4.197 | 3.019 | 0.795 | 0.317 | 0.041 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 11.2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 11.2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 185.341 | 8.987 | 62.113 | 57.207 | 0.976 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 4.248 | 3.226 | 3.274 | 2.567 | 1.699 | 1.043 | 0 |
| Total Non-Current Assets
| 224.876 | 30.482 | 69.584 | 62.793 | 3.47 | 1.36 | 0.041 |
| Total Assets
| 725.788 | 630.242 | 452.494 | 576.191 | 334.831 | 48.39 | 10.582 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 7.396 | 8.01 | 3.429 | 1.35 | 2.654 | 0.774 | 0.283 |
| Short Term Debt
| 1.061 | 0.483 | 1.162 | 1.375 | -0.363 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 4.144 | 3.314 | 0 | 0 | 0.363 | 0 | 0 |
| Other Current Liabilities
| 58.173 | 31.232 | 21.949 | 13.535 | 6.662 | 2.129 | 0.087 |
| Total Current Liabilities
| 78.17 | 51.049 | 29.969 | 17.61 | 11.97 | 3.677 | 0.653 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 5.996 | 4.768 | 0.129 | 1.359 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 15.403 | 16.233 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| -15.403 | -16.233 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 15.403 | 16.233 | 0 | 0.164 | 0.789 | 64.082 | 12.554 |
| Total Non-Current Liabilities
| 21.399 | 21.001 | 0.129 | 1.523 | 0.789 | 64.082 | 12.554 |
| Total Liabilities
| 99.569 | 72.05 | 30.098 | 19.133 | 12.759 | 67.759 | 13.207 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 334.831 | 2.014 | 2.014 |
| Common Stock
| 0.007 | 0.006 | 0.005 | 0.005 | 0.004 | 0 | 0 |
| Retained Earnings
| -895.034 | -569.93 | -292.513 | -118.603 | -73.029 | -22.452 | -4.639 |
| Accumulated Other Comprehensive Income/Loss
| 1.191 | -0.767 | -0.312 | 0.041 | -334.831 | 0 | 0 |
| Other Total Stockholders Equity
| 1,520.055 | 0.761 | 715.216 | 675.615 | 395.097 | 1.069 | 0 |
| Total Shareholders Equity
| 626.219 | -569.93 | 422.396 | 557.058 | 322.072 | -19.369 | -2.625 |
| Total Equity
| 626.219 | -569.93 | 422.396 | 557.058 | 322.072 | -19.369 | -2.625 |
| Total Liabilities & Shareholders Equity
| 725.788 | -497.88 | 452.494 | 576.191 | 334.831 | 48.39 | 10.582 |